Navigation Links
Basil Zimmo Joins Finesse Solutions as Vice-President of Software
Date:5/6/2008

SANTA CLARA, Calif., May 6 /PRNewswire/ -- Finesse Solutions, LLC, Santa Clara, CA, a manufacturer of measurement and control solutions for life sciences process applications, announced the appointment of Basil Zimmo as its Vice-President of Software. Basil brings over 19 years of international program and senior management experience, with a focus on implementing high efficiency engineering, resource optimization, and global performance metrics. Basil was most recently a Senior Program Manager for handheld products at Research in Motion (RIM). Prior to joining RIM, Basil held senior management roles at Picarro Canada, Inc. and telecommunications companies such as Nortel Networks and JDS Uniphase, and has held positions at semiconductor chip companies such as AMD, Mitel Semiconductor, Phillips Semiconductor, GEC Plessey and Hughes Aircraft Company.

At Finesse Solutions, Mr. Zimmo will lead the new, Santa Clara-based software team in developing the TruBio bioreactor control platform. Mr. Zimmo said, "I am delighted to join Finesse, and work closely with both sensor and hardware teams to develop the next generation TruBio software. Finesse has a unique opportunity to innovate and address the evolving needs of bio-processing applications."

According to Finesse Solutions CEO Dr. Barbara Paldus, "We are delighted to embark on developing future versions of TruBio software based on state-of-the art programming platforms, that will future-proof our offering and add new capabilities for end users. We look forward to offering end users significantly improved code and novel, advanced features in the near future."

About Finesse Solutions, LLC

California-based Finesse Solutions, LLC, leads the way in developing new measurement and control technologies, in order to enable the transition to single-use systems, bring new capabilities to existing bioreactor platforms, and harmonize global bio-process information transfer. Our current product family provides comprehensive measurement and control solutions for upstream processes in the biotech and pharmaceutical industries. For more information, please visit us at http://www.finesse.com.


'/>"/>
SOURCE Finesse Solutions, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Drugs from Johnson & Johnson/Basilea and Forest Are the Most Promising Antibiotics in the Community-Acquired Pneumonia Pipeline
2. Trisha Dowling Joins Biomatrica as Vice President, Sales and Marketing
3. Michael D. Taylor, Ph.D., Joins Cequent Pharmaceuticals Board of Directors
4. Harvey Morgan Joins CryoLife Board of Directors
5. Richard A. Schatz, M.D. Joins Cardiums Scientific Advisory Board
6. Dr. Arie S. Belldegrun, MD, FACS Joins Two River Group Holdings as Chairman and Partner
7. Robert W. Lee, Ph.D. Joins Particle Sciences as Vice President of Pharmaceutical Development
8. Dr. Elizabeth Brown Joins Argenta TEC
9. David S. Tierney, M.D., Joins Thomas, McNerney & Partners as Entrepreneur-In-Residence
10. Matthew J. Pfeffer Joins MannKind as Corporate Vice President and Chief Financial Officer
11. The Scripps Translational Science Institute Joins The MetaMiner Cardiac Consortium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... 23, 2017 /PRNewswire/ - The Fight Against Cancer Innovation ... (OICR) are pleased to report that Fusion Pharmaceuticals Inc. ... Johnson & Johnson Innovation – JJDC, Inc. (JJDC) as ... HealthCap, TPG Biotechnology Partners, and Genesys Capital, as well ... ...
(Date:2/23/2017)... , Feb. 23, 2017  Imanis Life ... product line of oncolytic vaccinia viruses for virotherapy ... as part of Genelux,s proprietary, vaccinia virus-based technology ... excited to enter into a partnership with Genelux ... oncolytic vaccinia viruses for use in research," said ...
(Date:2/23/2017)... ... , ... Today, researchers can fast-track sample collection and analysis ... biomarkers or SNPs of interest) using one, easy-to-collect saliva sample. With the addition ... insulin and other relevant biomarkers can be extensively studied through a non-invasive sample ...
(Date:2/23/2017)... SAN FRANCISCO , Feb. 23, 2017 /PRNewswire/ ... and Beyond Type 1, a not-for-profit advocacy and education ... announced a grant from Beyond Type 1 to support ... 1 and other insulin-requiring diabetes.  For ... stem cell-derived cell replacement therapies with a focus on ...
Breaking Biology Technology:
(Date:2/8/2017)... 2017 Report Highlights The global ... $8.3 billion in 2016 at a compound annual growth ... Report Includes - An overview of the global market ... data from 2015 and 2016, and projections of compound ... the market on the basis of product type, source, ...
(Date:2/7/2017)... BEACH, New York , February 7, 2017 /PRNewswire/ ... known as ID Global Solutions Corporation [OTC: IDGS], ("Ipsidy" ... identity management and electronic transaction processing services, is pleased ... reorganization of the Company. Effective January 31, ... of the Board of Directors, CEO and President.  An ...
(Date:2/3/2017)... A new independent identity strategy consultancy firm ... . Designed to fill a critical niche in technical ... partners Mark Crego and Janice Kephart ... identity expertise that span federal governments, the 9/11 Commission, ... combined expertise has a common theme born from a ...
Breaking Biology News(10 mins):